Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trials

被引:11
|
作者
Ahmer, Wania [1 ]
Imtiaz, Sahar [1 ]
Alam, Daniyal Muhammad [2 ]
Ahmed, Khadija [1 ]
Sajid, Barka [3 ]
Yousuf, Juvairia [1 ]
Asnani, Sunny [3 ]
Fahim, Muhammad Ahmed Ali [1 ]
Ali, Rahmeen [1 ]
Mansoor, Marium [4 ]
Safdar, Muhammad Talha [5 ]
Anjum, Muhammad Umair [1 ]
Hasanain, Muhammad [1 ]
Larik, Muhammad Omar [2 ]
机构
[1] Dow Med Coll, Dept Med, Karachi, Pakistan
[2] Dow Int Med Coll, Dept Med, Karachi, Pakistan
[3] Sindh Med Coll, Dept Med, Karachi, Pakistan
[4] Allama Iqbal Med Coll, Dept Med, Lahore, Pakistan
[5] Shaheed Mohtarma Benazir Bhutto Med Coll Lyari, Dept Med, Karachi, Pakistan
关键词
Remimazolam; Propofol; Endoscopy; Colonoscopy; Elderly; Meta-analysis; PROCEDURAL SEDATION; EFFICACY; SAFETY; ANESTHESIA; RECOVERY; TOSILATE; PAIN;
D O I
10.1007/s00228-024-03624-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose Propofol has become the sedative of choice for endoscopy and colonoscopy. However, it has shown associations with various adverse effects, specifically in the geriatric population. In contrast, remimazolam is a novel benzodiazepine, demonstrating a superior clinical safety profile. Hence, this systematic review and meta-analysis aims to clarify the efficacy and safety of remimazolam versus propofol in elderly patients (>= 60 years) undergoing gastrointestinal endoscopic and colonoscopy procedures.Methods Electronic databases including PubMed, Cochrane Library, ScienceDirect, and Google Scholar were explored from inception till January 7, 2024. The Cochrane Risk of Bias Tool for Randomized Controlled Trials (RoB-2) was utilized to evaluate the quality of each included study reported in this meta-analysis.Results Seven randomized control trials were included, resulting in the pooling of 1,466 patients (remimazolam: 731 patients; propofol: 735 patients). Propofol demonstrated a significantly lower time to loss of consciousness (P < 0.00001, 4 studies, 784 patients) and a greater sedation success after first dose (P = 0.05, 5 studies, 1,271 patients). Remimazolam reported a significantly lower risk of bradycardia (P = 0.02, 5 studies, 1,323 patients), hypoxemia (P < 0.00001, 6 studies, 1,389 patients), and pain on injection site (P < 0.00001, 5 studies, 1,184 patients). No statistically significant differences in sedation time, number of supplemental doses, procedural parameters, and other adverse outcomes were reported.Conclusion As per the results of our analyses, propofol demonstrated comparatively superior efficacy, however, remimazolam demonstrated comparatively superior safety. The debatable evidence generated from this meta-analysis may not currently be powerful enough to advocate for the use of remimazolam in elderly patients undergoing gastrointestinal procedures; hence, further comprehensive studies are necessary in order to arrive at a robust conclusion.
引用
收藏
页码:493 / 503
页数:11
相关论文
共 50 条
  • [21] Etomidate versus propofol for sedation in gastrointestinal endoscopy: A systematic review and meta-analysis of outcomes
    Hong, Ji Taek
    Park, Sung-Wook
    MEDICINE, 2023, 102 (06)
  • [22] The efficacy of ciprofol versus propofol on anesthesia in patients undergoing endoscopy: a systematic review and meta-analysis of randomized controlled trials
    Liu, Jikai
    Hong, Aonan
    Zeng, Jinfang
    Liang, Xiao
    BMC ANESTHESIOLOGY, 2024, 24 (01):
  • [23] Remimazolam versus propofol for procedural sedation and anesthesia: a systemic review and meta-analysis
    Zhang, Junbao
    Cairen, Zhuoma
    Shi, Liwen
    Pang, Shasha
    Shao, Yingjie
    Wang, Yun
    Lu, Zhihong
    MINERVA ANESTESIOLOGICA, 2022, 88 (12) : 1035 - 1042
  • [24] Propofol combined with traditional sedative agents versus propofol-alone sedation for gastrointestinal endoscopy: a meta-analysis
    Wang, Daorong
    Wang, Sen
    Chen, Jie
    Xu, Yaxiang
    Chen, Chaowu
    Long, Aihua
    Zhu, Zhen
    Liu, Jun
    Deng, Denghao
    Chen, Juan
    Tang, Dong
    Wang, Lu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (01) : 101 - 110
  • [25] Efficacy and Safety of Remimazolam for Procedural Sedation: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis
    Jhuang, Bo-Jyun
    Yeh, Bo-Han
    Huang, Yen-Ta
    Lai, Pei-Chun
    FRONTIERS IN MEDICINE, 2021, 8
  • [26] The Use of Propofol versus Dexmedetomidine for Patients Receiving Drug-Induced Sleep Endoscopy: A Meta-Analysis of Randomized Controlled Trials
    Chen, Yi-Ting
    Sun, Cheuk-Kwan
    Wu, Kuan-Yu
    Chang, Ying-Jen
    Chiang, Min-Hsien
    Chen, I-Wen
    Liao, Shu-Wei
    Hung, Kuo-Chuan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [27] Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients
    Astrid Kerker
    Christian Hardt
    Hans-Eugen Schlief
    Franz Ludwig Dumoulin
    BMC Gastroenterology, 10
  • [28] Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients
    Kerker, Astrid
    Hardt, Christian
    Schlief, Hans-Eugen
    Dumoulin, Franz Ludwig
    BMC GASTROENTEROLOGY, 2010, 10
  • [29] A meta-analysis of randomized controlled trials: combination of ketamine and propofol versus ketamine alone for procedural sedation and analgesia in children
    Hu, Yaofei
    Xu, Wujie
    Cao, Fei
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (07) : 1159 - 1165
  • [30] Safety and efficacy of propofol versus meperidine and midazolam for gastrointestinal endoscopic procedures: A meta-analysis of randomized controlled trials
    Enniss, DL
    Mandelblat, J
    Singh, R
    Bank, S
    Singh, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S247 - S247